J&J CEO Says Collective Effort Needed to Fight Omicron

The transcript discusses Johnson & Johnson's role in the COVID-19 pandemic, focusing on vaccine development, effectiveness against variants like Omicron, and global distribution efforts. It highlights the company's commitment to innovation and collaboration, exploring future vaccine technologies and the impact of the pandemic on business strategies. Leadership changes and the company's global health contributions are also covered.

What is the speaker's perspective on the importance of global vaccination?

How has the pandemic influenced Johnson and Johnson's business strategy?

What investments is Johnson and Johnson planning to make in research and development?

What legacy does the speaker hope to leave at Johnson and Johnson?